For research and educational purposes only. Not medical advice.
Linaclotide Reference
Educational, not medical advice reference for Linaclotide: GI; regulatory status, evidence posture, source review, and schedule notes. Also known as Linzess,…
Reference summary
Linaclotide is a label-verified guanylate cyclase-C agonist. pepSmart surfaces label-reference content only.
- Categories
- GI
- Aliases
- Linzess, Guanylate cyclase-C agonist
- Evidence posture
- human
- Regulatory status
- FDA-approved prescription medication (Linzess). Indicated for chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) in adults, and functional constipation in pediatric patients. Boxed warning against use in pediatric patients under 2 years (lethal dehydration in juvenile mice).
- Content review status
- label verified